Literature DB >> 23147702

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Anders Folkesson1, Lars Jelsbak, Lei Yang, Helle Krogh Johansen, Oana Ciofu, Niels Høiby, Søren Molin.   

Abstract

The airways of patients with cystic fibrosis (CF) are nearly always infected with many different microorganisms. This environment offers warm, humid and nutrient-rich conditions, but is also stressful owing to frequent antibiotic therapy and the host immune response. Pseudomonas aeruginosa is commonly isolated from the airways of patients with CF, where it most often establishes chronic infections that usually persist for the rest of the lives of the patients. This bacterium is a major cause of mortality and morbidity and has therefore been studied intensely. Here, we discuss how P. aeruginosa evolves from a state of early, recurrent intermittent colonization of the airways of patients with CF to a chronic infection state, and how this process offers opportunities to study bacterial evolution in natural environments. We believe that such studies are valuable not only for our understanding of bacterial evolution but also for the future development of new therapeutic strategies to treat severe chronic infections.

Entities:  

Mesh:

Year:  2012        PMID: 23147702     DOI: 10.1038/nrmicro2907

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  115 in total

1.  Genome evolution and adaptation in a long-term experiment with Escherichia coli.

Authors:  Jeffrey E Barrick; Dong Su Yu; Sung Ho Yoon; Haeyoung Jeong; Tae Kwang Oh; Dominique Schneider; Richard E Lenski; Jihyun F Kim
Journal:  Nature       Date:  2009-10-18       Impact factor: 49.962

2.  Adaptive radiation in a heterogeneous environment.

Authors:  P B Rainey; M Travisano
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

Review 3.  The bacterial glycocalyx in nature and disease.

Authors:  J W Costerton; R T Irvin; K J Cheng
Journal:  Annu Rev Microbiol       Date:  1981       Impact factor: 15.500

Review 4.  Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Nina Cramer; Lutz Wiehlmann; Burkhard Tümmler
Journal:  Int J Med Microbiol       Date:  2010-10-14       Impact factor: 3.473

Review 5.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.

Authors:  Michael Hogardt; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2010-10-12       Impact factor: 3.473

6.  MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa.

Authors:  Weihui Wu; Hassan Badrane; Shiwani Arora; Henry V Baker; Shouguang Jin
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

7.  Analysis of promoters controlled by the putative sigma factor AlgU regulating conversion to mucoidy in Pseudomonas aeruginosa: relationship to sigma E and stress response.

Authors:  D W Martin; M J Schurr; H Yu; V Deretic
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

8.  Microarray analysis of the osmotic stress response in Pseudomonas aeruginosa.

Authors:  Arden Aspedon; Kelli Palmer; Marvin Whiteley
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 9.  Cystic fibrosis.

Authors:  M R Bye; J M Ewig; L M Quittell
Journal:  Lung       Date:  1994       Impact factor: 2.584

10.  Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6.

Authors:  Susse Kirkelund Hansen; Janus A J Haagensen; Morten Gjermansen; Thomas Martini Jørgensen; Tim Tolker-Nielsen; Søren Molin
Journal:  J Bacteriol       Date:  2007-04-27       Impact factor: 3.490

View more
  288 in total

1.  Interspecific diversity reduces and functionally substitutes for intraspecific variation in biofilm communities.

Authors:  Kai Wei Kelvin Lee; Joey Kuok Hoong Yam; Manisha Mukherjee; Saravanan Periasamy; Peter D Steinberg; Staffan Kjelleberg; Scott A Rice
Journal:  ISME J       Date:  2015-09-25       Impact factor: 10.302

2.  Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.

Authors:  Veerle Liebens; Valerie Defraine; Wouter Knapen; Toon Swings; Serge Beullens; Romu Corbau; Arnaud Marchand; Patrick Chaltin; Maarten Fauvart; Jan Michiels
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 3.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

4.  Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Authors:  Jeremy R Dettman; Nicolas Rodrigue; Shawn D Aaron; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

5.  A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A.

Authors:  Iyarit Thaipisuttikul; Lauren E Hittle; Ramesh Chandra; Daniel Zangari; Charneal L Dixon; Teresa A Garrett; David A Rasko; Nandini Dasgupta; Samuel M Moskowitz; Lars Malmström; David R Goodlett; Samuel I Miller; Russell E Bishop; Robert K Ernst
Journal:  Mol Microbiol       Date:  2013-11-27       Impact factor: 3.501

6.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

7.  Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Ronald L Gibson; Bonnie W Ramsey; Hemantha D Kulasekara; George Z Retsch-Bogart; Wayne Morgan; Daniel J Wolter; Christopher E Pope; Laura S Houston; Bridget R Kulasekara; Umer Khan; Jane L Burns; Samuel I Miller; Lucas R Hoffman
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

8.  Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.

Authors:  Renan Marrichi Mauch; Claudio Lucio Rossi; Marcos Tadeu Nolasco da Silva; Talita Bianchi Aiello; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Niels Høiby; Carlos Emilio Levy
Journal:  Med Microbiol Immunol       Date:  2019-01-31       Impact factor: 3.402

Review 9.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

Review 10.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.